Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | TK1 | P04183 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195548 | 1.00 | PNP (0.55) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL114652 | 1.00 | PNP (0.55) | PNPCYP3A4MAPTADRB1DNMT1 | |
| Phosphoric Acid SCHEMBL9013988 | 0.96 | PNP (0.52) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL655857 | 0.90 | PNP (0.65) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL655858 | 0.90 | PNP (0.65) | PNPCYP3A4MAPTADRB1DNMT1 | |
| Citric Acid SCHEMBL3066161 | 0.89 | PNP (0.46) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL3868526 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL13351290 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL18723297 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 | |
| SCHEMBL14543297 | 0.88 | PNP (0.54) | PNPCYP3A4MAPTADRB1DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240153578-A1 | METHOD OF CHARACTERISING A CANCER | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-05-09 | — | — | US | disclosed |
| EP-4315339-A1 | METHOD OF CHARACTERISING A CANCER | Cambridge Enterprise Limited (GB) | 2024-02-07 | — | — | EP | disclosed |
| US-20230375446-A1 | REAGENT, KIT AND METHOD FOR STORING URINE SAMPLE | HEALTHCARE SYSTEMS CO., LTD. (JP) | 2023-11-23 | — | — | US | disclosed |
| EP-4276197-A2 | MAPPING THE LOCATION, TYPE AND STRAND OF DAMAGED NUCLEOTIDES IN DOUBLE-STRANDED DNA | New England Biolabs, Inc. (US) | 2023-11-15 | — | — | EP | disclosed |
| EP-4224161-A1 | REAGENT, KIT AND METHOD FOR STORING URINE SAMPLE | Healthcare Systems Co. Ltd. (JP) | 2023-08-09 | — | — | EP | disclosed |
| EP-3710596-B1 | MAPPING THE LOCATION, TYPE AND STRAND OF DAMAGED NUCLEOTIDES IN DOUBLE-STRANDED DNA | NEW ENGLAND BIOLABS INC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11713484-B2 | Mapping the location, type and strand of damaged and/or mismatched nucleotides in double-stranded DNA | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2023-08-01 | — | — | US | disclosed |
| CN-110714005-B | Functional microsphere for enriching oxidized nucleic acid and method for enriching oxidized nucleic acid | 青岛大学 | 2022-12-16 | — | — | CN | disclosed |
| WO-2022200293-A1 | METHOD OF CHARACTERISING A CANCER | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2022-09-29 | — | — | WO | disclosed |
| US-20200325533-A1 | Mapping the Location, Type and Strand of Damaged and/or Mismatched Nucleotides in Double-Stranded DNA | NEW ENGLAND BIOLABS, INC. (US) | 2020-10-15 | — | — | US | disclosed |
| US-10577481-B2 | Polymer | CANON KABUSHIKI KAISHA (JP) | 2020-03-03 | — | — | US | disclosed |
| CN-110714005-A | Functional microsphere for enriching oxidized nucleic acid and method for enriching oxidized nucleic acid | 青岛大学 | 2020-01-21 | — | — | CN | disclosed |
| CN-110564811-A | Method for enriching oxidized nucleic acids | 青岛大学 | 2019-12-13 | — | — | CN | disclosed |
| CN-108060206-A | Application of the metabolin of Physarum Polycephalum as biomarker | 深圳大学 | 2018-05-22 | — | — | CN | disclosed |
| CN-107208019-A | Methods and arrays for the generation and sequencing of nucleic acid monoclonal clusters | 伊鲁米纳剑桥有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107206037-A | Chrysanthemum extract and application thereof | I.B.R.以色列生物科技研究有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-107155304-A | Use of Secoisolariciresinol Diglucoside (SDG) and related compounds for protecting against radiation and chemical damage | 宾夕法尼亚大学董事会 | 2017-09-12 | — | — | CN | disclosed |
| CN-106999512-A | Novel formulations | 葛兰素史克消费保健（美国） 控股有限责任公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-105848681-A | Oxidized extracellular DNA moieties as stress biomarkers and methods of use thereof | 安娜·巴兰诺娃 | 2016-08-10 | — | — | CN | disclosed |
| CN-104830930-A | Nucleoside drug intermediate 2 '-deoxyguanosine production method | LESHAN RECONDEX BIOPHARMACEUTICAL CO LTD | 2015-08-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10577481-B2 | Polymer | OGG1, PCNA, DCLRE1A | PNP 1320/4885CYP3A4 3862/4885MAPT 4627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.